Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tachycardia, Ventricular | 11 | 2016 | 60 | 0.660 |
Why?
|
| Defibrillators, Implantable | 8 | 2003 | 45 | 0.630 |
Why?
|
| Catheter Ablation | 16 | 2018 | 220 | 0.570 |
Why?
|
| Wolff-Parkinson-White Syndrome | 6 | 2006 | 23 | 0.460 |
Why?
|
| Brugada Syndrome | 1 | 2012 | 4 | 0.410 |
Why?
|
| Fever | 1 | 2012 | 30 | 0.410 |
Why?
|
| Atrial Fibrillation | 6 | 2009 | 398 | 0.390 |
Why?
|
| Heart Atria | 4 | 2009 | 171 | 0.380 |
Why?
|
| Acute Coronary Syndrome | 1 | 2012 | 63 | 0.380 |
Why?
|
| Heart Conduction System | 14 | 2009 | 270 | 0.380 |
Why?
|
| Arrhythmias, Cardiac | 5 | 2013 | 163 | 0.350 |
Why?
|
| Electrocardiography | 13 | 2012 | 391 | 0.310 |
Why?
|
| Diverticulum | 2 | 2006 | 6 | 0.280 |
Why?
|
| Accessory Atrioventricular Bundle | 2 | 2018 | 17 | 0.270 |
Why?
|
| Anti-Arrhythmia Agents | 7 | 2005 | 117 | 0.260 |
Why?
|
| Action Potentials | 5 | 2018 | 194 | 0.260 |
Why?
|
| Atrioventricular Node | 4 | 2018 | 69 | 0.260 |
Why?
|
| Heart Rate | 3 | 2018 | 374 | 0.260 |
Why?
|
| Middle Aged | 32 | 2018 | 6820 | 0.260 |
Why?
|
| Ventricular Fibrillation | 5 | 2003 | 40 | 0.250 |
Why?
|
| Tachycardia | 9 | 2007 | 72 | 0.230 |
Why?
|
| Male | 34 | 2018 | 12874 | 0.210 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 4 | 2018 | 29 | 0.210 |
Why?
|
| Pulmonary Veins | 4 | 2009 | 107 | 0.210 |
Why?
|
| Troponin I | 1 | 2002 | 14 | 0.200 |
Why?
|
| Cardiac Pacing, Artificial | 7 | 2007 | 146 | 0.190 |
Why?
|
| Amiodarone | 3 | 1997 | 11 | 0.190 |
Why?
|
| Myocardium | 1 | 2002 | 171 | 0.180 |
Why?
|
| Humans | 43 | 2018 | 26846 | 0.180 |
Why?
|
| Follow-Up Studies | 16 | 2016 | 980 | 0.170 |
Why?
|
| Female | 32 | 2018 | 14466 | 0.160 |
Why?
|
| Adult | 23 | 2018 | 7384 | 0.160 |
Why?
|
| Aged | 23 | 2018 | 5168 | 0.160 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 367 | 0.160 |
Why?
|
| Coronary Vessels | 2 | 2013 | 151 | 0.150 |
Why?
|
| Pigmentation Disorders | 1 | 1997 | 8 | 0.150 |
Why?
|
| Cardiac Catheterization | 5 | 2007 | 112 | 0.140 |
Why?
|
| Treatment Outcome | 11 | 2018 | 2264 | 0.140 |
Why?
|
| Electric Countershock | 4 | 2005 | 29 | 0.130 |
Why?
|
| Hemodynamics | 2 | 1997 | 220 | 0.120 |
Why?
|
| Heart Injuries | 1 | 2013 | 8 | 0.110 |
Why?
|
| Cryosurgery | 1 | 2013 | 19 | 0.110 |
Why?
|
| Pericardium | 1 | 2013 | 47 | 0.110 |
Why?
|
| Adolescent | 13 | 2018 | 2957 | 0.100 |
Why?
|
| Electrocoagulation | 4 | 1992 | 20 | 0.100 |
Why?
|
| Equipment Design | 4 | 2016 | 211 | 0.100 |
Why?
|
| Pneumonia | 1 | 2012 | 89 | 0.100 |
Why?
|
| Bicarbonates | 1 | 1991 | 3 | 0.100 |
Why?
|
| Cocaine | 1 | 1991 | 22 | 0.090 |
Why?
|
| Sodium | 1 | 1991 | 47 | 0.090 |
Why?
|
| Cardiovascular System | 1 | 1991 | 39 | 0.090 |
Why?
|
| Syncope | 2 | 2001 | 10 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2018 | 2433 | 0.090 |
Why?
|
| Coronary Disease | 2 | 2009 | 118 | 0.090 |
Why?
|
| Recurrence | 7 | 2016 | 316 | 0.090 |
Why?
|
| Epicardial Mapping | 1 | 2009 | 8 | 0.080 |
Why?
|
| Myocardial Revascularization | 1 | 2009 | 14 | 0.080 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2009 | 70 | 0.080 |
Why?
|
| Time Factors | 6 | 2018 | 1562 | 0.080 |
Why?
|
| Electrophysiology | 6 | 2001 | 150 | 0.080 |
Why?
|
| Heart Ventricles | 4 | 2002 | 127 | 0.070 |
Why?
|
| Multivariate Analysis | 3 | 2002 | 298 | 0.070 |
Why?
|
| Catheterization | 1 | 2007 | 50 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2005 | 63 | 0.060 |
Why?
|
| Radio Waves | 4 | 1992 | 21 | 0.060 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2004 | 8 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2004 | 33 | 0.060 |
Why?
|
| Tachycardia, Supraventricular | 2 | 1996 | 23 | 0.060 |
Why?
|
| Heart Septum | 3 | 2002 | 16 | 0.050 |
Why?
|
| Dogs | 4 | 2007 | 504 | 0.050 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2002 | 4 | 0.050 |
Why?
|
| Creatine Kinase | 1 | 2002 | 13 | 0.050 |
Why?
|
| Incidence | 4 | 2005 | 545 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2002 | 86 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 802 | 0.050 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2001 | 16 | 0.050 |
Why?
|
| Atrial Flutter | 2 | 2001 | 13 | 0.050 |
Why?
|
| Models, Cardiovascular | 3 | 2002 | 46 | 0.040 |
Why?
|
| Risk Factors | 4 | 2013 | 2011 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2016 | 1216 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2000 | 68 | 0.040 |
Why?
|
| Monitoring, Physiologic | 2 | 2009 | 54 | 0.040 |
Why?
|
| Therapeutic Irrigation | 2 | 2016 | 19 | 0.040 |
Why?
|
| Coronary Angiography | 2 | 2013 | 149 | 0.040 |
Why?
|
| Electrodes | 4 | 2004 | 71 | 0.040 |
Why?
|
| Child | 7 | 2001 | 2147 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2016 | 1928 | 0.040 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2018 | 96 | 0.040 |
Why?
|
| Quality of Life | 2 | 2016 | 464 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2004 | 357 | 0.040 |
Why?
|
| Algorithms | 2 | 1998 | 419 | 0.040 |
Why?
|
| Hemorrhage | 3 | 2007 | 259 | 0.040 |
Why?
|
| Sulfonamides | 1 | 1997 | 69 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2001 | 213 | 0.030 |
Why?
|
| Tricuspid Valve | 1 | 1996 | 24 | 0.030 |
Why?
|
| Vena Cava, Inferior | 1 | 1996 | 16 | 0.030 |
Why?
|
| Device Approval | 1 | 2016 | 6 | 0.030 |
Why?
|
| Prognosis | 3 | 2005 | 759 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 472 | 0.030 |
Why?
|
| Microwaves | 1 | 1995 | 9 | 0.030 |
Why?
|
| Stroke Volume | 3 | 2003 | 111 | 0.030 |
Why?
|
| Pre-Excitation, Mahaim-Type | 1 | 1994 | 2 | 0.030 |
Why?
|
| Purkinje Fibers | 1 | 1993 | 37 | 0.030 |
Why?
|
| Pre-Excitation Syndromes | 1 | 1993 | 4 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2005 | 276 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1993 | 68 | 0.030 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1993 | 57 | 0.030 |
Why?
|
| Heart Failure | 2 | 2005 | 234 | 0.020 |
Why?
|
| Sodium Bicarbonate | 1 | 1991 | 5 | 0.020 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 1991 | 21 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1991 | 65 | 0.020 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1991 | 22 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 1995 | 578 | 0.020 |
Why?
|
| Survival Rate | 2 | 2001 | 406 | 0.020 |
Why?
|
| Animals | 4 | 2007 | 9962 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2001 | 1091 | 0.020 |
Why?
|
| Registries | 2 | 2001 | 383 | 0.020 |
Why?
|
| Ganglia, Autonomic | 1 | 2009 | 55 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2001 | 587 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 225 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 63 | 0.020 |
Why?
|
| Patient Selection | 1 | 2009 | 143 | 0.020 |
Why?
|
| Decision Making | 1 | 2009 | 169 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2007 | 34 | 0.020 |
Why?
|
| Phrenic Nerve | 1 | 2007 | 22 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2007 | 57 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 2582 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2007 | 228 | 0.020 |
Why?
|
| Cause of Death | 1 | 2005 | 66 | 0.020 |
Why?
|
| Heart Arrest | 1 | 2005 | 26 | 0.020 |
Why?
|
| Body Temperature | 2 | 1995 | 30 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2004 | 21 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2005 | 46 | 0.010 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2004 | 19 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2004 | 23 | 0.010 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2004 | 28 | 0.010 |
Why?
|
| Comorbidity | 1 | 2005 | 252 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 242 | 0.010 |
Why?
|
| Bundle-Branch Block | 2 | 1994 | 29 | 0.010 |
Why?
|
| Ventricular Function, Left | 2 | 1994 | 100 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 65 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2005 | 293 | 0.010 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2002 | 26 | 0.010 |
Why?
|
| Body Surface Potential Mapping | 1 | 2002 | 24 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 144 | 0.010 |
Why?
|
| Atrial Function, Right | 1 | 2001 | 4 | 0.010 |
Why?
|
| Fontan Procedure | 1 | 2001 | 24 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2001 | 205 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1997 | 36 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1997 | 99 | 0.010 |
Why?
|
| Endocardium | 1 | 1996 | 16 | 0.010 |
Why?
|
| Cardiology | 1 | 1996 | 47 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1997 | 351 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 586 | 0.010 |
Why?
|
| Hindlimb | 1 | 1995 | 20 | 0.010 |
Why?
|
| Electric Impedance | 1 | 1995 | 30 | 0.010 |
Why?
|
| Energy Transfer | 1 | 1995 | 7 | 0.010 |
Why?
|
| Heart Block | 1 | 1995 | 43 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1995 | 65 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1995 | 45 | 0.010 |
Why?
|
| Necrosis | 1 | 1995 | 81 | 0.010 |
Why?
|
| Bundle of His | 1 | 1995 | 55 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1995 | 84 | 0.010 |
Why?
|
| Ventricular Function | 1 | 1994 | 25 | 0.010 |
Why?
|
| Neural Conduction | 1 | 1994 | 24 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1993 | 43 | 0.010 |
Why?
|
| Radiography | 1 | 1993 | 200 | 0.010 |
Why?
|
| Software | 1 | 1993 | 121 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1993 | 508 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1991 | 67 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 1994 | 342 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1989 | 218 | 0.000 |
Why?
|
| Heart Function Tests | 1 | 1987 | 10 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1987 | 263 | 0.000 |
Why?
|